EVALUATION EARLY OUTCOME OF HOLMIUM LASER ENUCLEATION OF THE PROSTATE AT CAN THO UNIVERSITY OF MEDICINE AND PHARMACY HOSPITAL

Trung Hieu Nguyen1, , Thanh Tam Le1, Thanh Binh Le1, Minh Thai Ho1, Quoc Cuong Tran2, Huu Hoang Nguyen1
1 Can Tho University of Medicine and Pharmacy
2 Vinmec Can Tho International Hospital

Main Article Content

Abstract

Background: Holmium laser enucleation of the prostate (HoLEP) is the preferred treatment for large-volume benign prostatic hyperplasia; however, in Vietnam, this technique has not yet been widely implemented. Objectives: to evaluate the early outcomes of HoLEP at Can Tho University of Medicine and Pharmacy Hospital. Materials and methods: a prospective case series study was conducted from January 1, 2024, to May 30, 2025, at Can Tho University of Medicine and Pharmacy Hospital. Results: A total of 18 patients underwent HoLEP and were followed for 6 months postoperatively. The mean age was 70.61 ± 6.89 years. Improvements were observed in quality of life (QoL), International Prostate Symptom Score (IPSS), prostate-specific antigen (PSA), uroflowmetry parameters, and post-void residual urine volume. Regarding postoperative complications, two patients developed urinary tract infection, one experienced acute urinary retention after catheter removal, and one sustained bladder perforation. Conclusion: HoLEP is a feasible and highly effective treatment for benign prostatic hyperplasia with large prostate volumes. 

Article Details

References

1. Eredics K., Wachabauer D., Röthlin F., Mandersbacher S. and Schauer I.. Reoperation Rates and Mortality After Transurethral and Open Prostatectomy in a Long-term Nationwide Analysis: Have We Improved Over a Decade?. Urology. 2018. 118, 152-157, https://doi.org/10.1016/j.urology.2018.04.032.
2. Geavlete B., Bulai C., Ene C., Checherita I., and Geavlete P. Bipolar vaporization, resection, and enucleation versus open prostatectomy: optimal treatment alternatives in large prostate cases?. Journal of Endourology. 2015. 29(3), 323-331, https://doi.org/10.1089/end.2014.0493.
3. Reich, O., et al.Morbidity, mortality and early outcome of transurethral resection of the prostate: a prospective multicenter evaluation of 10,654 patients. J Urol. 2008. 180(1), p. 2469, https://doi.org/10.1016/j.juro.2008.03.058.
4. Bayraktar, N. and A.B. Başeskioğlu. Holmium Laser Enucleation of the Prostate (HoLEP) Versus Transurethral Resection of the Prostate (TURP) in Elderly Patients: Insights Into Recovery, Complications, and Risk Factors. Cureus. 2024. 16(12), p. E76384, https://doi.org/10.7759/cureus.76384.
5. Gilling P.J., Fraundorfer M.R. . Holmium LASER prostatectomy: a technique in evolution, Curr Opin Urol. 1998. 8(1), 11-15. https://doi.org/10.1097/00042307-199801000-00003
6. European Association of Urology. EAU Guidelines on Non-Neurogenic Male Lower Urinary Tract Symptoms. 2024. EAU Guideline. https://www.guidelinecentral.com/guideline/4543231/
7. Gravas S, Cornu JN, Gacci M, et al. Management of Non-Neurogenic Male Lower Urinary Tract Symptoms (LUTS), incl. Benign Prostatic Obstruction (BPO). 2022. EAU Guidelines. https://uroweb.org/guidelines/management-of-non-neurogenic-male-luts.
8. Võ Văn Chung, Đỗ Trường Thành. Đánh giá kết quả sớm bóc nhân phì đại lành tính tuyến tiền liệt bằng Holmium Laser qua đường niệu đạo tại Bệnh viện Hữu Nghị Hữu Đức. Tạp chí Y học Việt Nam. 2024. 509(2), tr.227-231, https://doi.org/10.51298/vmj.v509i2.1833.
9. Đỗ Trường Thành, Ngô Đậu Quyền, Nguyễn Đạo Uyên. Kết quả bóc nhân phì đại lành tính tuyến tiền liệt nội soi qua niệu đạo bằng Holmium-Laser tại Bệnh viện Hữu Nghị Việt Đức. Tạp chí Y học Việt Nam. 2023. 526(1B), tr.1-5, https://doi.org/10.51298/vmj.v526i1B.5384
10. Hồ Xuân Tuấn, Nguyễn Ngọc Chân, Trịnh Nguyên Bách. Đánh giá sớm kết quả bóc nhân tuyến tiền liệt bằng Laser Holmium trong điều trị bướu lành tuyến tiền liệt thể tích lớn tại Bệnh viện Bình Dân, Tạp chí Y học Việt Nam. 2021. 509 (số chuyên đề), tr.217-222, https://tapchiyhocvietnam.vn/index.php/vmj/article/view/10592.
11. Bộ Y tế. Hướng dẫn chẩn đoán và điều trị triệu chứng đường tiểu dưới do tăng sinh lành tính tuyến tiền liệt. 2023. số:1531/QĐ-BYT, Hà Nội.